ArrowMark Colorado Holdings’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-2,542,082
| Closed | -$216M | – | 362 |
|
|
2020
Q3 | $216M | Sell |
2,542,082
-849,461
| -25% | -$43M | 2.06% | 6 |
|
|
2020
Q2 | $120M | Sell |
3,391,543
-1,855,146
| -35% | -$54.2M | 1.24% | 27 |
|
|
2020
Q1 | $70.7M | Sell |
5,246,689
-146,080
| -3% | -$2.46M | 0.93% | 37 |
|
|
2019
Q4 | $114M | Buy |
5,392,769
+120,987
| +2% | +$2.13M | 1.01% | 34 |
|
|
2019
Q3 | $69.9M | Buy |
5,271,782
+561,432
| +12% | +$8.25M | 0.7% | 51 |
|
|
2019
Q2 | $65.3M | Buy |
4,710,350
+666,914
| +16% | +$10M | 0.63% | 61 |
|
|
2019
Q1 | $77.7M | Buy |
4,043,436
+67,216
| +2% | +$1.08M | 0.73% | 48 |
|
|
2018
Q4 | $56.7M | Buy |
3,976,220
+99,070
| +3% | +$1.97M | 0.6% | 60 |
|
|
2018
Q3 | $80.8M | Sell |
3,877,150
-435,021
| -10% | -$10.3M | 0.68% | 48 |
|
|
2018
Q2 | $102M | Sell |
4,312,171
-636,214
| -13% | -$12.8M | 0.94% | 30 |
|
|
2018
Q1 | $72.3M | Sell |
4,948,385
-276,739
| -5% | -$4.52M | 0.72% | 50 |
|
|
2017
Q4 | $84.4M | Buy |
5,225,124
+1,705,624
| +48% | +$20.1M | 0.85% | 37 |
|
|
2017
Q3 | $49.2M | Buy |
3,519,500
+2,096,383
| +147% | +$20.9M | 0.56% | 61 |
|
|
2017
Q2 | $12.6M | Sell |
1,423,117
-218,572
| -13% | -$1.53M | 0.16% | 130 |
|
|
2017
Q1 | $10.6M | Buy |
1,641,689
+117,214
| +8% | +$594K | 0.14% | 131 |
|
|
2016
Q4 | $5.59M | Buy |
1,524,475
+1,506,457
| +8,361% | +$4.46M | 0.09% | 173 |
|
|
2016
Q3 | $59K | Buy |
18,018
+1,359
| +8% | +$3.8K | ﹤0.01% | 294 |
|
|
2016
Q2 | $39K | Buy |
+16,659
| New | +$55.7K | ﹤0.01% | 273 |
|
ArrowMark Colorado Holdings's IMMU Position: Q4 2020 in Review
ArrowMark Colorado Holdings sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 2,542,082 shares — an estimated $216M sold.
ArrowMark Colorado Holdings first reported a position in IMMU in Q2 2016 and held it in 18 quarters. The position peaked at $216M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- ArrowMark Colorado Holdings reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- ArrowMark Colorado Holdings sold 2,542,082 Immunomedics Inc shares in Q4 2020, an estimated $216M.
- ArrowMark Colorado Holdings first reported a position in Immunomedics Inc in Q2 2016 and held it in 18 quarters.
- ArrowMark Colorado Holdings's Immunomedics Inc position peaked at $216M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on ArrowMark Colorado Holdings's 13F filing for Q4 2020, filed 16 Feb 2021.